Rhabdomyosarcoma has a robust NIH research funding landscape with 49 funded grants and $62.1M in total funding over the period.
3 new grants started in the last 12 months.
2 additional grants classified as “Other” (multi-disciplinary, infrastructure, etc.).
NIH fiscal year (Oct–Sep)
Comprehensive gap analysis requires both grant and publication data for Rhabdomyosarcoma.
Explore the publication landscape to help build the cross-domain picture.
These grants mention Rhabdomyosarcoma as part of broader research but are not primarily focused on this disease. They are not included in the funding totals above.
Track funding opportunities for Rhabdomyosarcoma.
Follow this disease to be notified about new NIH grants and funding changes.
Already have an account? Sign in to manage your watchlists.